Investor Information: Press Release

Printer Friendly Version View printer-friendly version
<< Back
PhotoMedex to Hold Second Quarter 2014 Conference Call on August 7th

HORSHAM, Pa.--(BUSINESS WIRE)--Aug. 4, 2014-- PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company’s second quarter 2014 financial results on Thursday, August 7, 2014 at 8:30 a.m. Eastern Time.

A press release to announce those results will be issued on August 7th, prior to the opening of the U.S. stock market.

To participate in the conference call, dial toll free 888-299-7209 or International/toll 719-325-2491 (and confirmation code # 5967523) approximately five to 10 minutes prior to the scheduled start time. For the convenience of our Israeli participants, a local/toll free number (1-80-924-5906) has been set up (the confirmation code remains the same # 5967523). If you are unable to participate, a digital replay of the call will be available from Thursday, August 7, from 11:30 a.m. ET to Thursday, August 21, 2014 at 11:30 a.m. ET, by dialing toll free 888-203-1112 or International/toll 719-457-0820 (Israeli participants may dial 1-80-924-6038) and using confirmation code # 5967523.

The live broadcast of PhotoMedex, Inc.’s quarterly conference call will be available online by going to and clicking on the link to Investor Relations, and at The online replay will be available shortly after the call at those sites.

About PhotoMedex

PhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The company provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. Its experience in the physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. As a result of its December 2011 merger with Radiancy, Inc., PhotoMedex has added a range of home-use devices under the no!no!™ brand, for various indications including hair removal, acne treatment and skin rejuvenation. The company also offers a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. PhotoMedex further expanded its base through the acquisition of LCA-Vision a leading provider of laser vision correction services under the LasikPlus® brand, operates 60 LasikPlus® vision centers in the United States: 51 full-service LasikPlus® fixed-site laser vision correction centers and nine pre- and post-operative LasikPlus® satellite centers. LCA-Vision has performed more than 1.3 million procedures since FDA approval of photorefractive keratectomy (PRK) in late 1995.

Source: PhotoMedex, Inc.

LHA, Inc.
Kim Sutton Golodetz (investors)
Bruce Voss
PhotoMedex, Inc.
Dennis McGrath, CFO